{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:07:06Z","timestamp":1793506026387,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CHMC Anesthesia Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adiponectin, a key adipokine primarily secreted by adipocytes, plays crucial roles in metabolic homeostasis and inflammation, exhibiting anti-diabetic, anti-atherogenic, and anti-inflammatory properties. Its various isoforms and signaling via receptors like AdipoR1, AdipoR2, and T-cadherin contribute to its diverse biological functions. Sepsis is a life-threatening syndrome triggered by a dysregulated host response to infection, leading to systemic inflammation, multi-organ failure, and high mortality, currently lacking specific treatments. Preclinical studies largely suggest a protective role for adiponectin, demonstrating that its deficiency exacerbates inflammation and endothelial dysfunction, while its administration or agonism improves outcomes in experimental sepsis models. Clinical findings, however, present a complex picture, with inconsistent correlations between adiponectin levels and sepsis outcomes reported, suggesting its potential as a dynamic biomarker influenced by disease stage, patient heterogeneity, and isoforms, rather than a simple prognostic factor. Notably, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in obesity and diabetes management, have been shown to increase adiponectin levels, linking metabolic therapies to potential sepsis immunomodulation. Consequently, targeting adiponectin signaling, either directly with adiponectin mimics like AdipoRon or indirectly via strategies like GLP-1RA administration, represents a promising therapeutic approach for sepsis. Harnessing the adiponectin axis holds potential for advancing precision medicine in critical care, necessitating further research into adiponectin-based interventions and synergistic metabolic therapies to improve sepsis outcomes.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13054-025-05516-2","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T11:23:27Z","timestamp":1752319407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Harnessing adiponectin for sepsis: current knowledge, clinical insights and future therapies"],"prefix":"10.1186","volume":"29","author":[{"given":"Stefano","family":"Gianoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten C.","family":"Odegard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Koutsogiannaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"10","key":"5516_CR1","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/ijms20102519","volume":"20","author":"S Parida","year":"2019","unstructured":"Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci. 2019;20(10):2519.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5516_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/ijms21041219","volume":"21","author":"HM Choi","year":"2020","unstructured":"Choi HM, Doss HM, Kim KS. Multifaceted physiological roles of adiponectin in inflammation and diseases. Int J Mol Sci. 2020;21(4):1219.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5516_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ijms18061321","volume":"18","author":"AE Achari","year":"2017","unstructured":"Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci. 2017;18(7):1321.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5516_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","volume":"121","author":"G Fantuzzi","year":"2008","unstructured":"Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol. 2008;121(2):326\u201330.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"5516_CR5","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.biochi.2012.06.008","volume":"94","author":"K Ohashi","year":"2012","unstructured":"Ohashi K, Ouchi N, Matsuzawa Y. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012;94(10):2137\u201342.","journal-title":"Biochimie"},{"issue":"1","key":"5516_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12032-013-0507-x","volume":"30","author":"T Kerenidi","year":"2013","unstructured":"Kerenidi T, Lada M, Tsaroucha A, Georgoulias P, Mystridou P, Gourgoulianis KI. Clinical significance of serum adipokines levels in lung cancer. Med Oncol. 2013;30(1):507.","journal-title":"Med Oncol"},{"issue":"12","key":"5516_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075535","volume":"8","author":"JH Yoon","year":"2013","unstructured":"Yoon JH, Kim SK, Choi HJ, Choi SI, Cha SY, Koh SB, Kang HT, Ahn SV. Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders. PLoS ONE. 2013;8(12): e75535.","journal-title":"PLoS ONE"},{"issue":"2","key":"5516_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","volume":"105","author":"N Esser","year":"2014","unstructured":"Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141\u201350.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"5516_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/08037051.2013.823767","volume":"23","author":"T di Chiara","year":"2014","unstructured":"di Chiara T, Licata A, Argano C, Duro G, Corrao S, Scaglione R. Plasma adiponectin: a contributing factor for cardiac changes in visceral obesity-associated hypertension. Blood Press. 2014;23(3):147\u201353.","journal-title":"Blood Press"},{"issue":"4","key":"5516_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10147-013-0603-0","volume":"19","author":"Y Ohbuchi","year":"2014","unstructured":"Ohbuchi Y, Suzuki Y, Hatakeyama I, Nakao Y, Fujito A, Iwasaka T, Isaka K. A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer. Int J Clin Oncol. 2014;19(4):667\u201373.","journal-title":"Int J Clin Oncol"},{"issue":"28","key":"5516_CR11","doi-asserted-by":"publisher","first-page":"10308","DOI":"10.1073\/pnas.0403382101","volume":"101","author":"C Hug","year":"2004","unstructured":"Hug C, Wang J, Ahmad NS, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin. Proc Natl Acad Sci USA. 2004;101(28):10308\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"5516_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(4):439\u201351.","journal-title":"Endocr Rev"},{"issue":"2","key":"5516_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/jmcb\/mjw012","volume":"8","author":"Y Luo","year":"2016","unstructured":"Luo Y, Liu M. Adiponectin: a versatile player of innate immunity. J Mol Cell Biol. 2016Apr;8(2):120\u20138.","journal-title":"J Mol Cell Biol"},{"key":"5516_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.acc.2018.02.007","volume":"85","author":"M van Andel","year":"2018","unstructured":"van Andel M, Heijboer AC, Drent ML. Adiponectin and its isoforms in pathophysiology. Adv Clin Chem. 2018;85:115\u201347.","journal-title":"Adv Clin Chem"},{"issue":"2","key":"5516_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165\u2013228.","journal-title":"Intensive Care Med"},{"issue":"8","key":"5516_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"10219","key":"5516_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020Jan 18;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"1","key":"5516_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s13054-023-04750-w","volume":"27","author":"A Tang","year":"2023","unstructured":"Tang A, Shi Y, Dong Q. Prognostic differences in sepsis caused by gram-negative bacteria and gram-positive bacteria: A systematic review and meta-analysis. Crit Care. 2023;27(1):467.","journal-title":"Crit Care"},{"issue":"6","key":"5516_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/pathogens13060461","volume":"13","author":"M Garvey","year":"2024","unstructured":"Garvey M. Hospital acquired sepsis, disease prevalence, and recent advances in sepsis mitigation. Pathogens. 2024May 30;13(6):461.","journal-title":"Pathogens"},{"issue":"4","key":"5516_CR20","volume":"51","author":"MI Cox","year":"2021","unstructured":"Cox MI, Voss H. Improving sepsis recognition and management. Curr Probl Pediatr Adolesc Health Care. 2021;51(4): 101001.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"2","key":"5516_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cmi.2020.02.022","volume":"27","author":"JW Uffen","year":"2021","unstructured":"Uffen JW, Oosterheert JJ, Schweitzer VA, et al. Interventions for rapid recognition and treatment of sepsis in the emergency department: a narrative review. Clin Microbiol Infect. 2021;27(2):192\u2013203.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"5516_CR22","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021Nov 9;54(11):2450\u201364.","journal-title":"Immunity"},{"issue":"1","key":"5516_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.CCM.0000194535.82812.BA","volume":"34","author":"GS Martin","year":"2006","unstructured":"Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15\u201321.","journal-title":"Crit Care Med"},{"issue":"12","key":"5516_CR24","doi-asserted-by":"publisher","first-page":"E762","DOI":"10.1002\/oby.20468","volume":"21","author":"HE Wang","year":"2013","unstructured":"Wang HE, Griffin R, Judd S, Shapiro NI, Safford MM. Obesity and risk of sepsis: a population-based cohort study. Obesity (Silver Spring). 2013;21(12):E762\u20139.","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"5516_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124838","volume":"10","author":"DP Henriksen","year":"2015","unstructured":"Henriksen DP, Pottegard A, Laursen CB, et al. Risk factors for hospitalization due to community-acquired sepsis - a population-based case-control study. PLoS ONE. 2015;10(4): e0124838.","journal-title":"PLoS ONE"},{"issue":"7","key":"5516_CR26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/CCM.0000000000001666","volume":"44","author":"HE Wang","year":"2016","unstructured":"Wang HE, Donnelly JP, Griffin R, et al. Derivation of novel risk prediction scores for community-acquired sepsis and severe sepsis. Crit Care Med. 2016;44(7):1285\u201394.","journal-title":"Crit Care Med"},{"issue":"5","key":"5516_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jcrc.2012.04.007","volume":"27","author":"DA Vassiliadi","year":"2012","unstructured":"Vassiliadi DA, Tzanela M, Kotanidou A, et al. Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels. J Crit Care. 2012;27(5):400\u20139.","journal-title":"J Crit Care"},{"issue":"5","key":"5516_CR28","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/jcm14051568","volume":"14","author":"K Yuki","year":"2025","unstructured":"Yuki K, Koutsogiannaki S. Obesity as a risk factor in pediatric sepsis: A retrospective comparative study under the Phoenix definition. J Clin Med. 2025;14(5):1568.","journal-title":"J Clin Med"},{"issue":"4","key":"5516_CR29","doi-asserted-by":"publisher","first-page":"E658","DOI":"10.1152\/ajpendo.90384.2008","volume":"295","author":"H Teoh","year":"2008","unstructured":"Teoh H, et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab. 2008;295(4):E658\u201364.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"5516_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.surg.2009.01.010","volume":"145","author":"Y Uji","year":"2009","unstructured":"Uji Y, et al. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery. 2009;145(5):550\u20137.","journal-title":"Surgery"},{"issue":"4","key":"5516_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s13679-019-00360-2","volume":"8","author":"I Karampela","year":"2019","unstructured":"Karampela I, Christodoulatos GS, Dalamaga M. The role of adipose tissue and adipokines in sepsis: inflammatory and metabolic considerations, and the obesity paradox. Curr Obes Rep. 2019;8(4):434\u201357.","journal-title":"Curr Obes Rep"},{"issue":"19","key":"5516_CR32","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.3390\/ijms20194820","volume":"20","author":"SH Loosen","year":"2019","unstructured":"Loosen SH, Koch A, Tacke F, et al. The role of adipokines as circulating biomarkers in critical illness and sepsis. Int J Mol Sci. 2019;20(19):4820.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"5516_CR33","doi-asserted-by":"publisher","first-page":"1153915","DOI":"10.3389\/fimmu.2023.1153915","volume":"19","author":"X Li","year":"2023","unstructured":"Li X, Ren Y, Chang K, et al. Adipose tissue macrophages as potential targets for obesity and metabolic diseases. Front Immunol. 2023Apr;19(14):1153915.","journal-title":"Front Immunol"},{"issue":"1","key":"5516_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3945\/an.115.010207","volume":"7","author":"CJ Andersen","year":"2016","unstructured":"Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016Jan 15;7(1):66\u201375.","journal-title":"Adv Nutr"},{"issue":"14","key":"5516_CR35","doi-asserted-by":"publisher","first-page":"1085799","DOI":"10.3389\/fendo.2023.1085799","volume":"1","author":"JY Wang","year":"2023","unstructured":"Wang JY, Wang QW, Yang XY, et al. GLP-1 receptor agonists for the treatment of obesity: role as a promising approach. Front Endocrinol (Lausanne). 2023Feb;1(14):1085799.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"5516_CR36","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1111\/bcp.14855","volume":"87","author":"LE Simental-Mendia","year":"2021","unstructured":"Simental-Mendia LE, Sanchez-Garcia A, Linden-Torres E, Simental-Mendia M. Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: a meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2021;87(11):4140\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"5516_CR37","doi-asserted-by":"publisher","unstructured":"Xie Y, Choi T, Al-Aly Z. Mapping the effectiveness and risks of GLP-1 receptor agonists. Nat Med. 2025 Mar;31(3):951\u2013962. https:\/\/doi.org\/10.1038\/s41591-024-03412-w. Epub 2025 Jan 20. Erratum in: Nat Med. 2025 Mar;31(3):1038.","DOI":"10.1038\/s41591-024-03412-w"},{"issue":"11","key":"5516_CR38","first-page":"136","volume":"3","author":"TMD Nguyen","year":"2020","unstructured":"Nguyen TMD. Adiponectin: role in physiology and pathophysiology. Int J Prev Med. 2020Sep;3(11):136.","journal-title":"Int J Prev Med"},{"issue":"1","key":"5516_CR39","doi-asserted-by":"publisher","first-page":"C203","DOI":"10.1152\/ajpcell.00030.2008","volume":"295","author":"MP Krause","year":"2008","unstructured":"Krause MP, Liu Y, Vu V, et al. Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function. Am J Physiol Cell Physiol. 2008;295(1):C203\u201312.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"5516_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/gut.2003.037010","volume":"54","author":"S Kaser","year":"2005","unstructured":"Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut. 2005;54(1):117\u201321.","journal-title":"Gut"},{"key":"5516_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154008","volume":"102","author":"SF Martinez-Huenchullan","year":"2020","unstructured":"Martinez-Huenchullan SF, Tam CS, Ban LA, et al. Skeletal muscle adiponectin induction in obesity and exercise. Metabolism. 2020Jan;102: 154008.","journal-title":"Metabolism"},{"issue":"5","key":"5516_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.12.003","volume":"14","author":"Y Han","year":"2024","unstructured":"Han Y, Sun Q, Chen W, et al. New advances of adiponectin in regulating obesity and related metabolic syndromes. J Pharm Anal. 2024May;14(5): 100913.","journal-title":"J Pharm Anal"},{"issue":"15","key":"5516_CR43","doi-asserted-by":"publisher","first-page":"1444884","DOI":"10.3389\/fimmu.2024.1444884","volume":"27","author":"L Zhang","year":"2024","unstructured":"Zhang L, Lin Y, Zhang Z, et al. Immune regulation and organ damage link adiponectin to sepsis. Front Immunol. 2024Nov;27(15):1444884.","journal-title":"Front Immunol"},{"key":"5516_CR44","unstructured":"Braun LM, Giesler S, Andrieux G, et al. Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity. Cancer Cell. 2025 Feb."},{"issue":"3","key":"5516_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012363","volume":"21","author":"SH Goli","year":"2025","unstructured":"Goli SH, Lim JY, Basaran-Akgul N, Templeton SP. Adiponectin pathway activation dampens inflammation and enhances alveolar macrophage fungal killing via LC3-associated phagocytosis. PLoS Pathog. 2025Mar 17;21(3): e1012363.","journal-title":"PLoS Pathog"},{"issue":"50","key":"5516_CR46","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"PE Scherer","year":"1995","unstructured":"Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270(50):26746\u20139.","journal-title":"J Biol Chem"},{"issue":"18","key":"5516_CR47","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","volume":"271","author":"E Hu","year":"1996","unstructured":"Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697\u2013703.","journal-title":"J Biol Chem"},{"issue":"1","key":"5516_CR48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","volume":"221","author":"K Maeda","year":"1996","unstructured":"Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221(1):286\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"5516_CR49","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a021483","volume":"120","author":"Y Nakano","year":"1996","unstructured":"Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996;120(4):803\u201312.","journal-title":"J Biochem"},{"issue":"52","key":"5516_CR50","first-page":"40352","volume":"278","author":"H Waki","year":"2003","unstructured":"Waki H, Yamauchi T, Kamon J, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Mol Biol Cell. 2003;278(52):40352\u201363.","journal-title":"Mol Biol Cell"},{"issue":"32","key":"5516_CR51","doi-asserted-by":"publisher","first-page":"29359","DOI":"10.1074\/jbc.C200312200","volume":"277","author":"TS Tsao","year":"2002","unstructured":"Tsao TS, Murrey HE, Hug C, et al. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem. 2002;277(32):29359\u201362.","journal-title":"J Biol Chem"},{"key":"5516_CR52","doi-asserted-by":"crossref","unstructured":"Tsao TS, Tomas E, Murrey HE, et al. Role of disulfide bonds in Acrp30\/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem. 2003;278(51):50810\u20137.","DOI":"10.1074\/jbc.M309469200"},{"issue":"5","key":"5516_CR53","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1210\/en.2007-1561","volume":"149","author":"T Schraw","year":"2008","unstructured":"Schraw T, Wang ZV, Halberg N, et al. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology. 2008;149(5):2270\u201382.","journal-title":"Endocrinology"},{"issue":"2","key":"5516_CR54","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/en.2004-1096","volume":"146","author":"H Waki","year":"2005","unstructured":"Waki H, Yamauchi T, Kamon J, et al. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology. 2005Feb;146(2):790\u20136.","journal-title":"Endocrinology"},{"issue":"3","key":"5516_CR55","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/oby.2011.316","volume":"20","author":"V Vachharajani","year":"2012","unstructured":"Vachharajani V, Cunningham C, Yoza B, et al. Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity (Silver Spring). 2012Mar;20(3):498\u2013504.","journal-title":"Obesity (Silver Spring)"},{"issue":"472","key":"5516_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.115174","volume":"24","author":"G Bai","year":"2024","unstructured":"Bai G, Ling J, Lu J, et al. Adiponectin receptor agonist AdipoRon alleviates memory impairment in the hippocampus of septic mice. Behav Brain Res. 2024Aug;24(472): 115174.","journal-title":"Behav Brain Res"},{"key":"5516_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115871","volume":"218","author":"SM Barbalho","year":"2023","unstructured":"Barbalho SM, M\u00e9ndez-S\u00e1nchez N, Fornari LL. AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review. Biochem Pharmacol. 2023Dec;218: 115871.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"5516_CR58","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.surg.2009.10.051","volume":"147","author":"L Siracusano","year":"2010","unstructured":"Siracusano L, Girasole V. Carbon monoxide and adiponectin in sepsis. Surgery. 2010May;147(5):755.","journal-title":"Surgery"},{"issue":"12","key":"5516_CR59","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/ars.2007.1762","volume":"9","author":"A Hoetzel","year":"2007","unstructured":"Hoetzel A, Dolinay T, Schmidt R, et al. Carbon monoxide in sepsis. Antioxid Redox Signal. 2007;9(12):2013\u201326.","journal-title":"Antioxid Redox Signal"},{"key":"5516_CR60","doi-asserted-by":"crossref","unstructured":"Sawle P, Foresti R, Mann BE, et al. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol. 2005;145(6):800\u201310.","DOI":"10.1038\/sj.bjp.0706241"},{"issue":"4","key":"5516_CR61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7150\/ijbs.4.270","volume":"4","author":"B Sun","year":"2008","unstructured":"Sun B, Zou X, Chen Y, et al. Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC. Int J Biol Sci. 2008;4(4):270\u20138.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"5516_CR62","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2337\/db07-1764","volume":"57","author":"M Li","year":"2008","unstructured":"Li M, Kim DH, Tsenovoy PL, et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes. 2008;57(6):1526\u201335.","journal-title":"Diabetes"},{"issue":"2","key":"5516_CR63","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1124\/jpet.108.148049","volume":"329","author":"S Lancel","year":"2009","unstructured":"Lancel S, Hassoun SM, Favory R, et al. Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis. J Pharmacol Exp Ther. 2009;329(2):641\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"5516_CR64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/08941939.2011.624257","volume":"25","author":"S Li","year":"2012","unstructured":"Li S, Bao HG, Han L, Liu L, Wang X. Effects of adiponectin on mortality and its mechanism in a sepsis mouse model. J Investig Surg. 2012;25(4):214\u20139.","journal-title":"J Investig Surg"},{"key":"5516_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380:24\u201330.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"5516_CR66","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-21-0159","volume":"252","author":"A Cinkajzlov\u00e1","year":"2021","unstructured":"Cinkajzlov\u00e1 A, Mr\u00e1z M, Haluz\u00edk M. Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases. J Endocrinol. 2021Nov 24;252(1):R1\u201322.","journal-title":"J Endocrinol"},{"issue":"9","key":"5516_CR67","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","volume":"285","author":"K Ohashi","year":"2010","unstructured":"Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem. 2010;285(9):6153\u201360.","journal-title":"J Biol Chem"},{"issue":"15","key":"5516_CR68","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1074\/jbc.M110.204644","volume":"286","author":"P Mandal","year":"2011","unstructured":"Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem. 2011;286(15):13460\u20139.","journal-title":"J Biol Chem"},{"key":"5516_CR69","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1038\/ncomms8687","volume":"6","author":"S Shibata","year":"2015","unstructured":"Shibata S, Tada Y, Hau C, et al. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from \u03b3\u03b4-T cells. Nat Commun. 2015;6:7687.","journal-title":"Nat Commun"},{"key":"5516_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.718929","volume":"12","author":"H Salvator","year":"2021","unstructured":"Salvator H, Grassin-Delyle S, Brollo M, Couderc LJ, Abrial C, Victoni T, et al. Adiponectin inhibits the production of TNF-\u03b1, IL-6 and chemokines by human lung macrophages. Front Pharmacol. 2021;12: 718929.","journal-title":"Front Pharmacol"},{"issue":"17","key":"5516_CR71","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1161\/01.CIR.0000127953.98131.ED","volume":"109","author":"M Kumada","year":"2004","unstructured":"Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation. 2004;109(17):2046\u20139.","journal-title":"Circulation"},{"issue":"2","key":"5516_CR72","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbrc.2004.08.145","volume":"323","author":"AM Wolf","year":"2004","unstructured":"Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323(2):630\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"5516_CR73","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"S Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam S, Mohammadian H, Vazini M, Taghadosi SA, Esmaeili F, Mardani B, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340.","journal-title":"J Cell Physiol"},{"key":"5516_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.644270","volume":"12","author":"X Shen","year":"2021","unstructured":"Shen X, Cao K, Zhao Y, Du J. Targeting neutrophils in sepsis: From mechanism to translation. Front Pharmacol. 2021;12: 644270.","journal-title":"Front Pharmacol"},{"issue":"12","key":"5516_CR75","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20207851","volume":"53","author":"CB Resende","year":"2020","unstructured":"Resende CB, Borges I, Gon\u00e7alves WA, Carneiro R, Rezende BM, Pinho V, et al. Neutrophil activity in sepsis: a systematic review. Braz J Med Biol Res. 2020;53(12): e7851.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"5516_CR76","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ajpath.2011.10.013","volume":"180","author":"P Chedid","year":"2012","unstructured":"Chedid P, Hurtado-Nedelec M, Marion-Gaber B, Bournier O, Hayem G, Gougerot-Pocidalo MA, et al. Adiponectin and its globular fragment differentially modulate the oxidative burst of primary human phagocytes. Am J Pathol. 2012;180(2):682\u201392.","journal-title":"Am J Pathol"},{"key":"5516_CR77","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10495-013-0893-8","volume":"18","author":"A Rossi","year":"2013","unstructured":"Rossi A, Lord JM. Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1\/2 MAP kinase. Apoptosis. 2013;18:1469\u201380.","journal-title":"Apoptosis"},{"issue":"5","key":"5516_CR78","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.intimp.2010.11.009","volume":"11","author":"JY Tsang","year":"2011","unstructured":"Tsang JY, Li D, Ho D, Peng J, Xu A, Lamb J, et al. Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int Immunopharmacol. 2011;11(5):604\u20139.","journal-title":"Int Immunopharmacol"},{"issue":"20","key":"5516_CR79","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1158\/0008-5472.CAN-13-1397","volume":"74","author":"PH Tan","year":"2014","unstructured":"Tan PH, Tyrrell HE, Gao L, Xu D, Quan J, Gill D, et al. Adiponectin receptor signaling on dendritic cells blunts antitumor immunity. Cancer Res. 2014;74(20):5711\u201322.","journal-title":"Cancer Res"},{"key":"5516_CR80","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/eji.201041349","volume":"41","author":"S Wilk","year":"2011","unstructured":"Wilk S, Scheibenbogen C, Bauer S, Jenke A, Rother M, Guerreiro M, et al. Adiponectin is a negative regulator of antigen-activated T cells. Eur J Immunol. 2011;41:2323\u201332.","journal-title":"Eur J Immunol"},{"key":"5516_CR81","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3389\/fimmu.2019.02555","volume":"10","author":"J Surendar","year":"2019","unstructured":"Surendar J, Frohberger SJ, Karunakaran I, Schmitt V, Stamminger W, Neumann AL, et al. Adiponectin limits IFN-\u03b3 and IL-17 producing CD4 T cells in obesity by restraining cell intrinsic glycolysis. Front Immunol. 2019;10:2555.","journal-title":"Front Immunol"},{"key":"5516_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677550","volume":"12","author":"P Ramos-Ram\u00edrez","year":"2021","unstructured":"Ramos-Ram\u00edrez P, Malmh\u00e4ll C, Tliba O, R\u00e5dinger M, Bossios A. Adiponectin\/AdipoR1 axis promotes IL-10 release by human regulatory T cells. Front Immunol. 2021;12: 677550.","journal-title":"Front Immunol"},{"key":"5516_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626310","volume":"12","author":"N Che","year":"2021","unstructured":"Che N, Sun X, Gu L, Wang X, Shi J, Sun Y, et al. Adiponectin enhances B-cell proliferation and differentiation via activation of Akt1\/STAT3 and exacerbates collagen-induced arthritis. Front Immunol. 2021;12: 626310.","journal-title":"Front Immunol"},{"key":"5516_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071271","volume":"8","author":"N Komura","year":"2013","unstructured":"Komura N, Maeda N, Mori T, Kihara S, Nakatsuji H, Hirata A, et al. Adiponectin protein exists in aortic endothelial cells. PLoS ONE. 2013;8: e71271.","journal-title":"PLoS ONE"},{"key":"5516_CR85","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/cvr\/cvn034","volume":"78","author":"K Mahadev","year":"2008","unstructured":"Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res. 2008;78:376\u201384.","journal-title":"Cardiovasc Res"},{"key":"5516_CR86","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.RES.0000194328.57164.36","volume":"97","author":"C Kobashi","year":"2005","unstructured":"Kobashi C, Urakaze M, Kishida M, Kibayashi E, Kobayashi H, Kihara S, et al. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res. 2005;97:1245\u201352.","journal-title":"Circ Res"},{"issue":"6","key":"5516_CR87","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1172\/JCI29623","volume":"117","author":"R Ouedraogo","year":"2007","unstructured":"Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, et al. Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest. 2007;117(6):1718\u201326.","journal-title":"J Clin Invest"},{"issue":"5","key":"5516_CR88","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/01.CIR.0000055188.83694.B3","volume":"107","author":"N Ouchi","year":"2003","unstructured":"Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in bloodstream and adipose tissue. Circulation. 2003;107(5):671\u20134.","journal-title":"Circulation"},{"issue":"2","key":"5516_CR89","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/biomedicines6020052","volume":"6","author":"T Gamberi","year":"2018","unstructured":"Gamberi T, Magherini F, Modesti A, Fiaschi T. Adiponectin signaling pathways in liver diseases. Biomedicines. 2018;6(2):52.","journal-title":"Biomedicines"},{"issue":"6","key":"5516_CR90","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2337\/db20-1073","volume":"70","author":"J Ryu","year":"2021","unstructured":"Ryu J, Hadley JT, Li Z, Dong F, Xu H, Xin X, et al. Adiponectin alleviates diet-induced inflammation in the liver by suppressing MCP-1 expression and macrophage infiltration. Diabetes. 2021;70(6):1303\u201316.","journal-title":"Diabetes"},{"key":"5516_CR91","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm724","volume":"8","author":"N Maeda","year":"2002","unstructured":"Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat Med. 2002;8:731\u20137.","journal-title":"Nat Med"},{"issue":"7","key":"5516_CR92","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/ijms20071782","volume":"20","author":"Y Kim","year":"2019","unstructured":"Kim Y, Park CW. Mechanisms of adiponectin action: Implication of adiponectin receptor agonism in diabetic kidney disease. Int J Mol Sci. 2019;20(7):1782.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5516_CR93","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1172\/JCI43464","volume":"120","author":"MS Denzel","year":"2010","unstructured":"Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest. 2010;120(12):4342\u201352.","journal-title":"J Clin Invest"},{"issue":"5","key":"5516_CR94","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/biomedicines11051290","volume":"11","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, Mart\u00edn-Rodr\u00edguez A, Mart\u00ednez-Guardado I, Navarro-Jim\u00e9nez E, Laborde-C\u00e1rdenas CC, Tornero-Aguilera JF. The Role of Adipokines in Health and Disease. Biomedicines. 2023;11(5):1290.","journal-title":"Biomedicines"},{"key":"5516_CR95","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2023.04.001","volume":"203","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Sun N, Song X, Zhu J, Wang T, Wang Z, Yu Y, Ren J, Chen H, Zhan T, Tian J, Ma C, Huang J, Wang J, Zhang Y, Yang B. A novel small molecule AdipoR2 agonist ameliorates experimental hepatic steatosis in hamsters and mice. Free Radic Biol Med. 2023Jul;203:69\u201385.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5516_CR96","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1210\/en.2006-0708","volume":"148","author":"Y Liu","year":"2007","unstructured":"Liu Y, Michael MD, Kash S, Bensch WR, Monia BP, Murray SF, Otto KA, Syed SK, Bhanot S, Sloop KW, Sullivan JM, Reifel-Miller A. Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology. 2007Feb;148(2):683\u201392.","journal-title":"Endocrinology"},{"key":"5516_CR97","doi-asserted-by":"publisher","first-page":"10690","DOI":"10.1038\/s41467-024-55295-7","volume":"15","author":"R Wang","year":"2024","unstructured":"Wang R, Chen Y, Han J, et al. Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure. Nat Commun. 2024;15:10690.","journal-title":"Nat Commun"},{"issue":"1","key":"5516_CR98","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13054-019-2315-y","volume":"23","author":"WK Yu","year":"2019","unstructured":"Yu WK, McNeil JB, Wickersham NE, Shaver CM, Bastarache JA, Ware LB. Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury. Crit Care. 2019Jan 18;23(1):18.","journal-title":"Crit Care"},{"key":"5516_CR99","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/cc10021","volume":"15","author":"K Robinson","year":"2011","unstructured":"Robinson K, Prins J, Venkatesh B. Clinical review: Adiponectin biology and its role in inflammation and critical illness. Crit Care. 2011;15:221.","journal-title":"Crit Care"},{"key":"5516_CR100","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2482-10-26","volume":"10","author":"A Hillenbrand","year":"2010","unstructured":"Hillenbrand A, Knippschild U, Weiss M, Schrezenmeier H, Henne-Bruns D, Huber-Lang M, et al. Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surg. 2010;10:26.","journal-title":"BMC Surg"},{"key":"5516_CR101","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12950-016-0138-z","volume":"13","author":"A Hillenbrand","year":"2016","unstructured":"Hillenbrand A, Xu P, Zhou S, et al. Circulating adipokine levels and prognostic value in septic patients. J Inflamm. 2016;13:30.","journal-title":"J Inflamm"},{"issue":"4","key":"5516_CR102","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1186\/cc7941","volume":"13","author":"B Venkatesh","year":"2009","unstructured":"Venkatesh B, Hickman I, Nisbet J, Cohen J, Prins J. Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care. 2009;13(4):R105.","journal-title":"Crit Care"},{"key":"5516_CR103","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcrc.2020.06.020","volume":"60","author":"HX Wang","year":"2020","unstructured":"Wang HX, Gao YX, Wu YN, Li C, Duan J. Association between plasma adiponectin levels and left ventricular systolic dysfunction in sepsis patients. J Crit Care. 2020;60:195\u2013201.","journal-title":"J Crit Care"},{"key":"5516_CR104","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13054-016-1244-2","volume":"20","author":"JA Palakshappa","year":"2016","unstructured":"Palakshappa JA, Anderson BJ, Reilly JP, Shashaty MG, Ueno R, Wu Q, Ittner CA, Tommasini A, Dunn TG, Charles D, Kazi A, Christie JD, Meyer NJ. Low plasma levels of adiponectin do not explain acute respiratory distress syndrome risk: a prospective cohort study of patients with severe sepsis. Crit Care. 2016;20:71.","journal-title":"Crit Care"},{"key":"5516_CR105","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jcrc.2010.07.015","volume":"26","author":"A Koch","year":"2011","unstructured":"Koch A, et al. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care. 2011;26:166\u201374.","journal-title":"J Crit Care"},{"key":"5516_CR106","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1097\/CCM.0b013e3181fa0561","volume":"38","author":"AJ Walkey","year":"2010","unstructured":"Walkey AJ, et al. Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med. 2010;38:2329\u201334.","journal-title":"Crit Care Med"},{"key":"5516_CR107","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jcrc.2017.05.004","volume":"41","author":"I Karampela","year":"2017","unstructured":"Karampela I, et al. Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: A prospective study. J Crit Care. 2017;41:78\u201385.","journal-title":"J Crit Care"},{"key":"5516_CR108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2253-14-124","volume":"14","author":"ID Welters","year":"2014","unstructured":"Welters ID, Bing C, Ding C, Leuwer M, Hall AM. Circulating anti-inflammatory adipokines high molecular weight adiponectin and zinc-alpha2-glycoprotein (ZAG) are inhibited in early sepsis, but increase with clinical recovery: a pilot study. BMC Anesthesiol. 2014;14:124.","journal-title":"BMC Anesthesiol"},{"issue":"4","key":"5516_CR109","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc7956","volume":"13","author":"L Langouche","year":"2009","unstructured":"Langouche L, Vander Perre S, Frystyk J, Flyvbjerg A, Hansen TK, Van den Berghe G. Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care. 2009;13(4):R112. https:\/\/doi.org\/10.1186\/cc7956.","journal-title":"Crit Care"},{"key":"5516_CR110","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jcrc.2014.12.007","volume":"30","author":"V Trivedi","year":"2015","unstructured":"Trivedi V, Bavishi C, Jean R. Impact of obesity on sepsis mortality: A systematic review. J Crit Care. 2015;30:518\u201324.","journal-title":"J Crit Care"},{"key":"5516_CR111","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13054-016-1360-z","volume":"20","author":"DJ Pepper","year":"2016","unstructured":"Pepper DJ, et al. Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2016;20:181.","journal-title":"Crit Care"},{"key":"5516_CR112","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12871-017-0405-4","volume":"17","author":"S Wang","year":"2017","unstructured":"Wang S, et al. The role of increased body mass index in outcomes of sepsis: a systematic review and meta-analysis. BMC Anesthesiol. 2017;17:118.","journal-title":"BMC Anesthesiol"},{"key":"5516_CR113","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/CCM.0000000000003692","volume":"47","author":"DJ Pepper","year":"2019","unstructured":"Pepper DJ, et al. Does obesity protect against death in sepsis? A retrospective cohort study of 55,038 adult patients. Crit Care Med. 2019;47:643\u201350.","journal-title":"Crit Care Med"},{"key":"5516_CR114","doi-asserted-by":"publisher","first-page":"e776","DOI":"10.1097\/CCM.0000000000004459","volume":"48","author":"N Jagan","year":"2020","unstructured":"Jagan N, Morrow LE, Walters RW, et al. Sepsis and the obesity paradox: Size matters in more than one way. Crit Care Med. 2020;48:e776\u201382.","journal-title":"Crit Care Med"},{"key":"5516_CR115","doi-asserted-by":"crossref","unstructured":"Yeo HJ, Kim TH, Jang JH, Jeon K, Oh DK, Park MH, Lim CM, Kim K, Cho WH; Korean Sepsis Alliance (KSA) Investigators. Obesity paradox and functional outcomes in sepsis: A multicenter prospective study. Crit Care Med. 2023;51(6):742\u2013752.","DOI":"10.1097\/CCM.0000000000005801"},{"key":"5516_CR116","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1155\/2012\/672939","volume":"33","author":"K Indulekha","year":"2012","unstructured":"Indulekha K, Surendar J, Anjana RM, Gokulakrishnan K, Balasubramanyam M, Aravindhan V, Mohan V. Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress, and inflammation in Asian Indians. Dis Markers. 2012;33:185\u201392.","journal-title":"Dis Markers"},{"key":"5516_CR117","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2019.07.011","volume":"288","author":"GK Pandey","year":"2019","unstructured":"Pandey GK, Vadivel S, Raghavan S, Mohan V, Balasubramanyam M, Gokulakrishnan K. High molecular weight adiponectin reduces glucolipotoxicity-induced inflammation and improves lipid metabolism and insulin sensitivity via APPL1-AMPK-GLUT4 regulation in 3T3-L1 adipocytes. Atherosclerosis. 2019;288:67\u201375.","journal-title":"Atherosclerosis"},{"key":"5516_CR118","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.febslet.2008.04.037","volume":"582","author":"Y Hattori","year":"2008","unstructured":"Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K, Kasai K. High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-\u03baB activation in vascular endothelial cells. FEBS Lett. 2008;582:1719\u201324.","journal-title":"FEBS Lett"},{"key":"5516_CR119","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","volume":"51","author":"H Nishizawa","year":"2002","unstructured":"Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51:2734\u201341.","journal-title":"Diabetes"},{"issue":"1","key":"5516_CR120","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1530\/eje.1.01930","volume":"153","author":"T Isobe","year":"2005","unstructured":"Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, et al. Influence of gender, age and renal function on plasma adiponectin level: The Tanno and Sobetsu study. Eur J Endocrinol. 2005;153(1):91\u20138.","journal-title":"Eur J Endocrinol"},{"key":"5516_CR121","doi-asserted-by":"crossref","unstructured":"Martin M, et al. Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care. 2008.","DOI":"10.2337\/dc07-1781"},{"issue":"12","key":"5516_CR122","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1751-7176.2010.00383.x","volume":"12","author":"J Cui","year":"2010","unstructured":"Cui J, Wu X, Andrel J, Falkner B. Relationships of total adiponectin and molecular weight fractions of adiponectin with free testosterone in African men and premenopausal women. J Clin Hypertens (Greenwich). 2010;12(12):957\u201363.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"5516_CR123","unstructured":"King GA, et al. Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol. 2012."},{"key":"5516_CR124","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2318-14-8","volume":"14","author":"HJ Song","year":"2014","unstructured":"Song HJ, Oh S, Quan S, Ryu OH, Jeong JY, Hong KS, Kim DH. Gender differences in adiponectin levels and body composition in older adults: Hallym aging study. BMC Geriatr. 2014;14:8.","journal-title":"BMC Geriatr"},{"key":"5516_CR125","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6823-11-13","volume":"11","author":"RI Pereira","year":"2011","unstructured":"Pereira RI, Wang CC, Hosokawa P, Dickinson LM, Chonchol M, Krantz MJ, et al. Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures. BMC Endocr Disord. 2011;11:13.","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"5516_CR126","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.metabol.2012.02.005","volume":"61","author":"UI Khan","year":"2012","unstructured":"Khan UI, Wang D, Sowers MR, Mancuso P, Everson-Rose SA, Scherer PE, Wildman RP. Race-ethnic differences in adipokine levels: the Study of Women\u2019s Health Across the Nation (SWAN). Metabolism. 2012;61(9):1261\u20139.","journal-title":"Metabolism"},{"key":"5516_CR127","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1475-2840-12-170","volume":"12","author":"DC Sulistyoningrum","year":"2013","unstructured":"Sulistyoningrum DC, Gasevic D, Lear SA, et al. Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol. 2013;12:170.","journal-title":"Cardiovasc Diabetol"},{"issue":"1\u20132","key":"5516_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cca.2007.11.017","volume":"389","author":"SJ Koh","year":"2008","unstructured":"Koh SJ, Hyun YJ, Choi SY, Chae JS, Kim JY, Park S, et al. Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance. Clin Chim Acta. 2008;389(1\u20132):45\u201350.","journal-title":"Clin Chim Acta"},{"issue":"1\u20133","key":"5516_CR129","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.regpep.2011.04.003","volume":"169","author":"IM Kruger","year":"2011","unstructured":"Kruger IM, Huisman HW, Schutte AE. The relationship between adiponectin, ageing, and renal function in a bi-ethnic sample. Regul Pept. 2011;169(1\u20133):58\u201363.","journal-title":"Regul Pept"},{"issue":"4","key":"5516_CR130","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-07-0512","volume":"158","author":"J Polak","year":"2008","unstructured":"Polak J, Kovacova Z, Holst C, Verdich C, Astrup A, Blaak E, et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur J Endocrinol. 2008Apr;158(4):533\u201341.","journal-title":"Eur J Endocrinol"},{"key":"5516_CR131","doi-asserted-by":"publisher","first-page":"6532860","DOI":"10.1155\/2016\/6532860","volume":"2016","author":"U Skalska","year":"2016","unstructured":"Skalska U, Kontny E. Adiponectin Isoforms and Leptin Impact on Rheumatoid Adipose Mesenchymal Stem Cells Function. Stem Cells Int. 2016;2016:6532860.","journal-title":"Stem Cells Int"},{"issue":"3","key":"5516_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192609","volume":"13","author":"M Iwata","year":"2018","unstructured":"Iwata M, Hara K, Kamura Y, Honoki H, Fujisaka S, Ishiki M, et al. Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance. PLoS ONE. 2018Mar 1;13(3): e0192609.","journal-title":"PLoS ONE"},{"key":"5516_CR133","doi-asserted-by":"crossref","unstructured":"Matsumoto Y, Toyomasu K, Uchimura N, Ishitake T. Low-molecular-weight adiponectin is more closely associated with episodes of asthma than high-molecular-weight adiponectin. Endocr J. 2013.","DOI":"10.1507\/endocrj.EJ12-0277"},{"issue":"7","key":"5516_CR134","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/ijms21072620","volume":"21","author":"M Abou-Samra","year":"2020","unstructured":"Abou-Samra M, Selvais CM, Dubuisson N, Brichard SM. Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills\u2026 or Everything Together? Int J Mol Sci. 2020Apr 9;21(7):2620.","journal-title":"Int J Mol Sci"},{"key":"5516_CR135","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fendo.2019.00842","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Vu V, Sweeney G. Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases. Front Endocrinol (Lausanne). 2019;10:842.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"5516_CR136","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fcvm.2019.00116","volume":"14","author":"M Iwabu","year":"2019","unstructured":"Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T. Adiponectin\/AdipoR Research and Its Implications for Lifestyle-Related Diseases. Front Cardiovasc Med. 2019Aug;14(6):116.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"5516_CR137","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018097","volume":"10","author":"A Jenke","year":"2021","unstructured":"Jenke A, Yazdanyar M, Miyahara S, Chekhoeva A, Immohr MB, Kistner J, et al. AdipoRon Attenuates Inflammation and Impairment of Cardiac Function Associated With Cardiopulmonary Bypass-Induced Systemic Inflammatory Response Syndrome. J Am Heart Assoc. 2021Mar 16;10(6): e018097.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"5516_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.718929","volume":"23","author":"H Salvator","year":"2021","unstructured":"Salvator H, Grassin-Delyle S, Brollo M, Couderc LJ, Abrial C, Victoni T, et al. Adiponectin Inhibits the Production of TNF-\u03b1, IL-6 and Chemokines by Human Lung Macrophages. Front Pharmacol. 2021Aug;23(12): 718929.","journal-title":"Front Pharmacol"},{"issue":"13","key":"5516_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.875900","volume":"4","author":"KE Cohen","year":"2022","unstructured":"Cohen KE, Katunaric B, Schulz ME, SenthilKumar G, Young MS, Mace JE, et al. Role of Adiponectin Receptor 1 in Promoting Nitric Oxide-Mediated Flow-Induced Dilation in the Human Microvasculature. Front Pharmacol. 2022Apr;4(13): 875900.","journal-title":"Front Pharmacol"},{"key":"5516_CR140","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami KI, Matsuda K, et al. A small-molecule adipor agonist for type 2 diabetes and short life in obesity. Nature. 2013;503:493\u20139.","journal-title":"Nature"},{"issue":"8","key":"5516_CR141","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.3168\/jds.2022-22723","volume":"106","author":"C Zhao","year":"2023","unstructured":"Zhao C, Wu B, Li J, Jiang Q, Loor JJ, Liu M, et al. AdipoRon alleviates fatty acid-induced lipid accumulation and mitochondrial dysfunction in bovine hepatocytes by promoting autophagy. J Dairy Sci. 2023Aug;106(8):5763\u201374.","journal-title":"J Dairy Sci"},{"issue":"10","key":"5516_CR142","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.3390\/molecules26102946","volume":"26","author":"H Zatorski","year":"2021","unstructured":"Zatorski H, Salaga M, Zieli\u0144ska M, Majchrzak K, Binienda A, Kordek R, et al. AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice. Molecules. 2021;26(10):2946.","journal-title":"Molecules"},{"issue":"229","key":"5516_CR143","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.freeradbiomed.2025.01.018","volume":"1","author":"Y Qian","year":"2025","unstructured":"Qian Y, Qi Y, Lin J, Zhang T, Mo L, Xue Q, et al. AdipoRon ameliorates chronic ethanol induced cardiac necroptosis by reducing ceramide mediated mtROS. Free Radic Biol Med. 2025Mar;1(229):237\u201350.","journal-title":"Free Radic Biol Med"},{"issue":"20","key":"5516_CR144","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1097\/CM9.0000000000000488","volume":"132","author":"WZ Xiao","year":"2019","unstructured":"Xiao WZ, Zhang L. Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice. Chin Med J (Engl). 2019Oct 20;132(20):2438\u201345.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"5516_CR145","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fendo.2019.00539.PMID:31456747;PMCID:PMC6700268","volume":"13","author":"L Otvos Jr","year":"2019","unstructured":"Otvos L Jr. Potential Adiponectin Receptor Response Modifier Therapeutics. Front Endocrinol (Lausanne). 2019Aug;13(10):539. https:\/\/doi.org\/10.3389\/fendo.2019.00539.PMID:31456747;PMCID:PMC6700268.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"5516_CR146","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1210\/clinem\/dgac276","volume":"107","author":"N Kumar","year":"2022","unstructured":"Kumar N, D\u2019Alessio DA. Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight Loss. J Clin Endocrinol Metab. 2022Aug;107(8):2148\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"152","key":"5516_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114390","volume":"16","author":"W Fan","year":"2025","unstructured":"Fan W, Zhang Q, Wang C, Sun J, Zhang J, Yin Y. GLP-1 as a regulator of sepsis outcomes: Insights into cellular metabolism, inflammation, and therapeutic potential. Int Immunopharmacol. 2025Apr;16(152): 114390.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"5516_CR148","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.2337\/db14-0100","volume":"63","author":"F Kahles","year":"2014","unstructured":"Kahles F, Meyer C, M\u00f6llmann J, Diebold S, Findeisen HM, Lebherz C, et al. GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6\u2013Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering. Diabetes. 2014Oct;63(10):3221\u20139.","journal-title":"Diabetes"},{"issue":"12","key":"5516_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.706908","volume":"14","author":"F Yang","year":"2021","unstructured":"Yang F, Zeng F, Luo X, Lei Y, Li J, Lu S, et al. GLP-1 Receptor: A New Target for Sepsis. Front Pharmacol. 2021Jul;14(12): 706908.","journal-title":"Front Pharmacol"},{"issue":"3","key":"5516_CR150","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4093\/dmj.2023.0277","volume":"48","author":"T Bu","year":"2024","unstructured":"Bu T, Sun Z, Pan Y, Deng X, Yuan G. Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism. Diabetes Metab J. 2024May;48(3):354\u201372.","journal-title":"Diabetes Metab J"},{"issue":"12","key":"5516_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.44","volume":"6","author":"E Pastel","year":"2016","unstructured":"Pastel E, Joshi S, Knight B, Liversedge N, Ward R, Kos K. Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling. Nutr Diabetes. 2016Dec 12;6(12): e235.","journal-title":"Nutr Diabetes"},{"key":"5516_CR152","doi-asserted-by":"crossref","unstructured":"Sato T, Shimizu T, Fujita H, Imai Y, Drucker DJ, Seino Y, et al. GLP-1 Receptor Signaling Differentially Modifies the Outcomes of Sterile vs Viral Pulmonary Inflammation in Male Mice. Endocrinology. 2020 Dec;161(12):bqaa201.","DOI":"10.1210\/endocr\/bqaa201"},{"issue":"3","key":"5516_CR153","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrneph.2016.186","volume":"13","author":"H G\u00f3mez","year":"2017","unstructured":"G\u00f3mez H, Kellum JA, Ronco C. Metabolic reprogramming and tolerance during sepsis-induced AKI. Nat Rev Nephrol. 2017Mar;13(3):143\u201351.","journal-title":"Nat Rev Nephrol"},{"issue":"23","key":"5516_CR154","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.3390\/ijms20236024","volume":"20","author":"JH Choi","year":"2019","unstructured":"Choi JH, Kim SJ, Kwon SK, Kim HY, Jeon H. Renal Tubular Glucagon-Like Peptide-1 Receptor Expression Is Increased in Early Sepsis but Reduced in Chronic Kidney Disease and Sepsis-Induced Kidney Injury. Int J Mol Sci. 2019;20(23):6024.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5516_CR155","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/thorax-2024-221906","volume":"80","author":"AE Henney","year":"2024","unstructured":"Henney AE, Riley DR, Hydes TJ, Anson M, Ibarburu GH, Frost F, et al. Comparative estimate of glucose-lowering therapies on risk of incident pneumonia and severe sepsis: an analysis of real-world cohort data. Thorax. 2024Dec 23;80(1):32\u201341.","journal-title":"Thorax"},{"key":"5516_CR156","first-page":"A1108","volume":"209","author":"L Aman","year":"2024","unstructured":"Aman L, Obeidalla S, Bastarache JA, Baer B, Wei WQ, Feng Q, et al. Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Reduced Sepsis and Organ Injury in Adults Hospitalized With Infection. Am J Respir Crit Care Med. 2024;209:A1108.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05516-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:23:25Z","timestamp":1757226205000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":156,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5516"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05516-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This article is a review of previously published literature and does not involve any studies with human participants or animals performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. This article does not contain any individual person\u2019s data in any form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"300"}}